News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Barrans Russell
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/09/2021 |
4
| Barrans Russell (Chief Commercial Officer) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 19,998 shares
@ $0.975, valued at
$19.5k
|
|
| 06/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2021 |
4
| Barrans Russell (Chief Commercial Officer) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Granted 200,000 shares
@ $0
Granted 150,000 options to buy
@ $3.25, valued at
$487.5k
|
|
| 09/11/2020 |
4
| Barrans Russell (Chief Commercial Officer) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Bought 1,000 shares
@ $2.71, valued at
$2.7k
Bought 3,000 shares
@ $2.08, valued at
$6.2k
|
|
| 07/09/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/08/2020 |
4
| Barrans Russell (Chief Commercial Officer) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 15,455 shares
@ $3.31, valued at
$51.2k
|
|
| 05/26/2020 |
4
| Barrans Russell (Chief Commercial Officer) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 19,474 shares
@ $4.99, valued at
$97.2k
|
|
| 05/08/2020 |
4
| Barrans Russell (Chief Commercial Officer) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 3,802 shares
@ $5.24, valued at
$19.9k
|
|
| 02/21/2020 |
4
| Barrans Russell (Chief Commercial Officer) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Sold 14,957 shares
@ $6.5, valued at
$97.2k
|
|
| 02/07/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/21/2020 |
4
| Barrans Russell (Chief Commercial Officer) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Sold 1,578 shares
@ $6.5, valued at
$10.3k
|
|
| 11/26/2019 |
4
| Barrans Russell (Chief Commercial Officer) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 9,277 shares
@ $6.22, valued at
$57.7k
|
|
| 11/21/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/26/2019 |
4
| Barrans Russell (Chief Commercial Officer) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 962 shares
@ $5.13, valued at
$4.9k
|
|
| 07/10/2019 |
4
| Barrans Russell (Chief Commercial Officer) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Granted 150,000 shares
@ $0
Paid exercise price by delivering 13,257 shares
@ $4.99, valued at
$66.2k
|
|
| 06/12/2019 |
4
| Barrans Russell (Chief Commercial Officer) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 5,965 shares
@ $6.36, valued at
$37.9k
|
|
| 04/03/2019 |
4
| Barrans Russell (Chief Commercial Officer) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 1,160 shares
@ $3.55, valued at
$4.1k
|
|
| 11/29/2018 |
4
| Barrans Russell (Chief Commercial Officer) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Granted options to buy
@ $3.45, valued at
$0 |
|
| 11/26/2018 |
4
| Barrans Russell (Chief Commercial Officer) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Bought 279 shares
@ $3.55, valued at
$990.5 |
|
| 08/13/2018 |
4
| Barrans Russell (Chief Commercial Officer) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Bought 3,715 shares
@ $1.98, valued at
$7.4k
|
|
| 07/03/2018 |
4
| Barrans Russell (Chief Commercial Officer) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Granted 11,666 shares
@ $0
Paid exercise price by delivering 2,840 shares
@ $2.46, valued at
$7k
|
|
| 03/14/2018 |
4
| Barrans Russell (Chief Commercial Officer) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Granted 260,000 options to buy
@ $7.29, valued at
$1.9M
|
|
| 01/18/2018 |
4
| Barrans Russell (Chief Commercial Officer) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Granted 3,850 options to buy
@ $46.36, valued at
$178.5k
Granted 1,283 options to buy
@ $46.36, valued at
$59.5k
|
|
|
|